Company Profile

Novilytic LLC (AKA: Intelimmune LLC)
Profile last edited on: 9/19/22      CAGE: 556A9      UEI: CK86X1TB2U91

Business Identifier: Reducing cost, inconvenience and pain of blood testing
Year Founded
2007
First Award
2011
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1281 Win Hentschel Boulevard
West Lafayette, IN 47906
   (574) 834-2406
   info@novilytic.com
   www.novilytic.com
Location: Multiple
Congr. District: 04
County: Tippecanoe

Public Profile

Novilytic LLC - formerly doing business as Intelimmune LLC, - is developing new methods by which to detect biomarkers .. the diagnostic tool to identify the specific biological condition of molecules in the human body. Using the biomarkers, researchers can determine if someone has a variety of cancers or even high cholesterol. Novilytic specializes in the application of quantitative LC/MS/MS tandem mass spectrometry to provide the researcher with reliable results permitting identification and comparative study of peptides, metabolites, drugs, and other biomarkers. The firm is structured particularly around reducing the cost, inconvenience and pain of blood testing in both humans and animals and enabling testing anytime and anywhere with its ground-breaking Noviplex Plasma Prep Card. These cards quickly prepare plasma from a drop of blood in just 3 minutes with the resulting plasma deal for LC/MS tests and immunoassays used in clinical diagnostics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,427,968
Project Title: The Proteometer; a Continuous Upstream Process Monitoring Engine
2018 2 NIH $1,739,071
Project Title: Sample Preparation; the Achilles Heel of Mass Spectrometry Based Diagnostics
2015 2 NIH $1,069,917
Project Title: A New Method for the Analysis of Vitamin D

Key People / Management

  Paul Dreier -- Chief Executive Officer

  Jiri Adamec -- Chief Scientific Officer

  Jinhee Kim -- Director of Analytics

  Fred E Regnier -- Chief Technology Officer

  Tim Schlabach -- Director Sales & Marketing

  Tim Woenker -- COO

Company News